NCT00731263 - A Study of Tor Kinase Inhibitor in Advanced Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Solid Tumors

Interventions

DRUG

AZD8055

Oral solution or tablet, single dose on Day 1 Part A, twice daily ascending dosing from day 8 onwards (until maximum tolerated dose is reached), cycles of 28 days treatment.

Trial Locations (4)

10065

Research Site, New York

Unknown

Research Site, Houston

Research Site, Clichy

Research Site, Sutton